Gliclazide and Bystolic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gliclazide (gliclazide) and Bystolic (nebivolol hydrochloride). Common drug interactions include abdominal discomfort among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Gliclazide and Bystolic. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Bystolic?

Bystolic has active ingredients of nebivolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 20,662 Bystolic users. Check the latest studies of Bystolic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

26 people who take Gliclazide and Bystolic together, and have interactions are studied.

Gliclazide and Bystolic drug interactions.

What are the common drug interactions of Gliclazide and Bystolic, by gender? *:

female:

Abdominal discomfort
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Diarrhoea
Drug ineffective
Injection site bruising
Injection site pain
Nausea (feeling of having an urge to vomit)
Synovial cyst (cyst of joint filled with synovial fluid)
Meningioma (a diverse set of tumours arising from the meninges)
Pain in extremity

male:

Dyspnoea (difficult or laboured respiration)
Hypoxia (low oxygen in tissues)
Glycosylated haemoglobin increased
Headache (pain in head)
Influenza
Injection site abscess
Injection site cellulitis (injection site inflammation)
Injection site haemorrhage (bleeding from injection site)
Injection site infection
Injection site inflammation

What are the common drug interactions of Gliclazide and Bystolic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Meningioma (a diverse set of tumours arising from the meninges)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
Behcet's syndrome (involves inflammation of the blood vessels)
Depression
Incoherent (talking in a confused and unclear way)
Weight increased

40-49:

Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Alcohol use
Blood glucose increased
Blood thyroid stimulating hormone decreased
Drug ineffective
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Erectile dysfunction
Erythema (redness of the skin)
Flushing (the warm, red condition of human skin)

50-59:

Balance disorder
Blood creatinine increased
Pancreatitis (inflammation of pancreas)
Tremor (trembling or shaking movements in one or more parts of your body)

60+:

Dyspnoea (difficult or laboured respiration)
Hypoxia (low oxygen in tissues)
Injection site pain
Nausea (feeling of having an urge to vomit)
Pain in extremity
Synovial cyst (cyst of joint filled with synovial fluid)
Abdominal discomfort
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Concussion (short loss of normal brain function in response to a head injury)
Death

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 19.23%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 19.23%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 15.38%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 11.54%
Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 3 people, 11.54%
Type 2 Diabetes: 2 people, 7.69%
Sleep Disorder: 2 people, 7.69%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and Bystolic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously